INTERNATIONAL PATENT: ANTIBE THERAPEUTICS INC. FILES APPLICATION FOR "PHENYLTHIONE-2,3-DIHYDRO-1H-PYRROLIZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF USEFUL AS H2S-RELEASING KETOROLAC ANALOGUES"

GENEVA, April 5 -- ANTIBE THERAPEUTICS INC. (15 Prince Arthur AvenueToronto, Ontario M5R 1B2) filed a patent application (PCT/CA2024/051289) for "PHENYLTHIONE-2,3-DIHYDRO-1H-PYRROLIZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF USEFUL AS H2S-RELEASING KETOROLAC ANALOGUES" on Sep 26, 2024. With publication no. WO/2025/065102, the details related to the patent application was published on Apr 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VAUGHAN, David J. (15 Prince Arthur AvenueToronto, Ontario M5R 1B2), TO, Quang Huy (146 San Remo DriveHamilton, Ontario L9C 5T9), DOVE, Peter ...